Lars A. Akslen
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.05%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Angiogenesis and VEGF in Cancer 43
- Oncology 102
- Cancer Cells and Metastasis 28
- Cutaneous Melanoma Detection and Management 27
- Co-authors
- Charles M. Perou (4 shared papers)Matt van de Rijn (3 shared papers)Per Eystein Lønning (12 shared papers)Hilde Johnsen (4 shared papers)Oddbjørn Straume (44 shared papers)Helga B. Salvesen (60 shared papers)Øystein Fluge (8 shared papers)Thérese Sørlie (4 shared papers)
- Journals
- PLoS ONE (17 papers)International Journal of Cancer (16 papers)Apmis (14 papers)Clinical Cancer Research (13 papers)Cancer Research (12 papers)
- Partner nations
- NorwayUnited StatesSweden
In The Last Decade
Lars A. Akslen
309 papers receiving 29.6k citations
Lars A. Akslen's Hit Papers
Peers
Comparison fields: 5 of 171
- Cancer Research 9.8k
- Oncology 11.1k
- Obstetrics and Gynecology 1.2k
- Molecular Biology 12.1k
- Pathology and Forensic Medicine 2.4k
Countries citing papers authored by Lars A. Akslen
This map shows the geographic impact of Lars A. Akslen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars A. Akslen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars A. Akslen more than expected).
Fields of papers citing papers by Lars A. Akslen
This network shows the impact of papers produced by Lars A. Akslen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars A. Akslen. The network helps show where Lars A. Akslen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars A. Akslen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 319 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular portraits of human breast tumours Hit paper breakdown → | 2000 | 12287 |
| 2 | Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Hit paper breakdown → | 2004 | 2179 |
| 3 | EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the Endometrium, Prostate, and Breast Hit paper breakdown → | 2005 | 711 |
| 4 | Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Hit paper breakdown → | 1996 | 641 |
| 5 | 2009 | 474 | |
| 6 | A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer Hit paper breakdown → | 2007 | 457 |
| 7 | 2009 | 409 | |
| 8 | 2006 | 400 | |
| 9 | 2006 | 339 | |
| 10 | 2004 | 311 | |
| 11 | 2007 | 305 | |
| 12 | 2009 | 285 | |
| 13 | 2006 | 230 | |
| 14 | 2013 | 192 | |
| 15 | Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma. | 2000 | 185 |
| 16 | 2000 | 183 | |
| 17 | 2005 | 177 | |
| 18 | 2005 | 159 | |
| 19 | Independent prognostic impact of lymphatic vessel density and presence of low-grade lymphangiogenesis in cutaneous melanoma. | 2003 | 158 |
| 20 | 1999 | 152 |
About Lars A. Akslen
Lars A. Akslen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 319 papers that have together received 30.5k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (43 papers), Breast Cancer Treatment Studies (33 papers), Cancer Genomics and Diagnostics (29 papers), Cancer Cells and Metastasis (28 papers), Cutaneous Melanoma Detection and Management (27 papers), Thyroid Cancer Diagnosis and Treatment (22 papers), Endometrial and Cervical Cancer Treatments (21 papers) and Prostate Cancer Treatment and Research (13 papers). The work is most often cited by research in Cancer Research (9.8k citations), Oncology (11.1k citations), Obstetrics and Gynecology (1.2k citations), Molecular Biology (12.1k citations) and Pathology and Forensic Medicine (2.4k citations). Lars A. Akslen has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Charles M. Perou, Matt van de Rijn, Per Eystein Lønning, Hilde Johnsen, Oddbjørn Straume, Helga B. Salvesen, Øystein Fluge, Thérese Sørlie, David Botstein and Shirley Zhu. Their work appears in journals such as PLoS ONE, International Journal of Cancer, Apmis, Clinical Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.